BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19128381)

  • 1. Scleral wrap increases the long-term complication risk of bone-derived hydroxyapatite orbital implants.
    Toh T; Bevin TH; Molteno AC
    Clin Exp Ophthalmol; 2008 Nov; 36(8):756-61. PubMed ID: 19128381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term follow up of bone derived hydroxyapatite orbital implants.
    Suter AJ; Molteno AC; Bevin TH; Fulton JD; Herbison P
    Br J Ophthalmol; 2002 Nov; 86(11):1287-92. PubMed ID: 12386091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases.
    Yoon JS; Lew H; Kim SJ; Lee SY
    Ophthalmology; 2008 Mar; 115(3):566-572.e2. PubMed ID: 17854900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porous orbital implants, wraps, and PEG placement in the pediatric population after enucleation.
    Wang JK; Liao SL; Lin LL; Kao SC; Tseng HS
    Am J Ophthalmol; 2007 Jul; 144(1):109-116. PubMed ID: 17499206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of exposure of porous orbital implants following enucleation.
    Wang JK; Liao SL; Lai PC; Lin LL
    Am J Ophthalmol; 2007 Jan; 143(1):61-67. PubMed ID: 17109809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine pericardium versus homologous sclera as a wrapping for hydroxyapatite orbital implants.
    Arat YO; Shetlar DJ; Boniuk M
    Ophthalmic Plast Reconstr Surg; 2003 May; 19(3):189-93. PubMed ID: 12918552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late exposure of the bioceramic orbital implant.
    Wang JK; Lai PC; Liao SL
    Am J Ophthalmol; 2009 Jan; 147(1):162-170.e1. PubMed ID: 18571617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of autogenous sclera as wrapping material in hydroxyapatite implantation.
    Yoon JS; Lew H; Kook KH; Lee SY
    Ophthalmologica; 2009; 223(1):7-11. PubMed ID: 18849630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the exposure rate of wrapped hydroxyapatite (Bio-Eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients.
    Tabatabaee Z; Mazloumi M; Rajabi MT; Khalilzadeh O; Kassaee A; Moghimi S; Eftekhar H; Goldberg RA
    Ophthalmic Plast Reconstr Surg; 2011; 27(2):114-8. PubMed ID: 20829725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyapatite orbital implant in children following enucleation: analysis of 531 sockets.
    Shah SU; Shields CL; Lally SE; Shields JA
    Ophthalmic Plast Reconstr Surg; 2015; 31(2):108-14. PubMed ID: 24896774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orbital implants in retinoblastoma patients: 23 years of experience and a review of the literature.
    Mourits DL; Moll AC; Bosscha MI; Tan HS; Hartong DT
    Acta Ophthalmol; 2016 Mar; 94(2):165-74. PubMed ID: 26603132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary banked scleral patch graft in the prevention of exposure of hydroxyapatite orbital implants.
    Inkster CF; Ng SG; Leatherbarrow B
    Ophthalmology; 2002 Feb; 109(2):389-92. PubMed ID: 11825828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative motility of hydroxyapatite and alloplastic enucleation implants.
    Custer PL; Trinkaus KM; Fornoff J
    Ophthalmology; 1999 Mar; 106(3):513-6. PubMed ID: 10080207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of natural hydroxyapatite implants covered with Vicryl® mesh in a series of 704 enucleations].
    Ricaud X; Levy-Gabriel C; Lumbroso-Le Rouic L; Cassoux N; Esteve M; Plancher C; Asselain B; Desjardins L
    J Fr Ophtalmol; 2014 Feb; 37(2):99-106. PubMed ID: 24210936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mersilene mesh versus sclera in wrapping hydroxyapatite orbital implants.
    Kassaee A; Kashkouli MB; Panjtanpanah M; Sadeghi A; Tabatabaee Z
    Ophthalmic Plast Reconstr Surg; 2006; 22(1):41-4. PubMed ID: 16418664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of mersilene mesh for wrapping of hydroxyapatite orbital implants: mid-term result.
    Owji N; Mosallaei M; Taylor J
    Orbit; 2012 Jun; 31(3):155-8. PubMed ID: 22551365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of sclera-covered enucleation implants.
    Custer PL; McCaffery S
    Ophthalmic Plast Reconstr Surg; 2006; 22(4):269-73. PubMed ID: 16855498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology.
    Custer PL; Kennedy RH; Woog JJ; Kaltreider SA; Meyer DR
    Ophthalmology; 2003 Oct; 110(10):2054-61. PubMed ID: 14522788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior surface breakdown and implant extrusion following secondary alloplastic orbital implantation surgery.
    Axmann S; Paridaens D
    Acta Ophthalmol; 2018 May; 96(3):310-313. PubMed ID: 29220117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of hydroxyapatite orbital implants. A review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping.
    Oestreicher JH; Liu E; Berkowitz M
    Ophthalmology; 1997 Feb; 104(2):324-9. PubMed ID: 9052640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.